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Abstract Pathological gambling (PG) is characterized by continual repeated gambling
behavior despite negative consequences. PG is considered to be a disorder of altered
decision-making under risk, and behavioral economics tools were utilized by studies on
decision-making under risk. At the same time, PG was suggested to be a heterogeneous
disorder in terms of personality traits as well as risk attitude. We aimed to examine the
heterogeneity of PG in terms of loss aversion, which means that a loss is subjectively felt to
be larger than the same amount of gain. Thirty-one male PG subjects and 26 male healthy
control (HC) subjects underwent a behavioral economics task for estimation of loss
aversion and personality traits assessment. Although loss aversion in PG subjects was not
significantly different from that in HC subjects, distributions of loss aversion differed
between PG and HC subjects. HC subjects were uniformly classified into three levels (low,
middle, high) of loss aversion, whereas PG subjects were mostly classified into the two
extremes, and few PG subjects were classified into the middle range. PG subjects with low
and high loss aversion showed a significant difference in anxiety, excitement-seeking and
craving intensity. Our study suggested that PG was a heterogeneous disorder in terms of
loss aversion. This result might be useful for understanding cognitive and neurobiological
mechanisms and the establishment of treatment strategies for PG.
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Introduction
Pathological gambling (PG) is a chronic psychiatric disorder characterized by continual
repeated gambling behavior despite negative consequences. In addition to PG patients
themselves, their families and workplaces sometimes face serious consequences. Although
PG was classified by the Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition Text-Revision (DSM-IV-TR) (American Psychiatric Association 2000) as ‘‘Im-
pulse-Control Disorder Not Elsewhere Classified’’, according to the Diagnostic and Sta-
tistical Manual of Mental Disorders 5th Edition (DSM-5) (American Psychiatric
Association 2013), it is classified into ‘‘Substance-Related and Addictive Disorders’’.
Although PG is classified into the same category as substance-use addictions in DSM-5,
it has a specific behavior and a different diagnostic criterion from substance-use addictions
called ‘‘chasing’’. Chasing is considered a continual gambling behavior in order to regain
lost money and almost always results in a more miserable situation. Continual gambling
despite continual defeat may be attributed to altered decision-making under risk. Recently,
in order to clarify altered decision-making in neuropsychiatric disorders, tools of the
behavioral economics field have been utilized in clinical psychiatry. One of the most
influential and successful theories of decision-making under risk is the prospect theory
(Kahneman and Tversky 1979). A core part of the prospect theory is the probability weight
function, which is expressed by an inverse S-shaped curve. This function shows that higher
probability tends to be underestimated and lower probability tends to be overestimated.
Previous studies investigated a neural substrate (Hsu et al. 2009) and a molecular mech-
anism (Takahashi et al. 2010) of this function. Another core part of the prospect theory is
the value function, which is expressed as a loose, concave slope in a gain area, and a steep,
convex slope in a loss area. Generally, the susceptibility to loss is stronger than that to gain
as, for example, few people try a gamble that has a 50–50 chance of winning and losing the
same amount of money. This psychological trait is called loss aversion, meaning that a loss
is felt to be larger subjectively than the same amount of gain, even if they are objectively
equivalent. Loss aversion is expressed as a steeper slope in a loss area than that in a gain
area. Previous studies investigating the neural substrate of loss aversion suggested that
striatum (Chib et al. 2012; Tom et al. 2007) and amygdala (De Martino et al. 2010) are
involved in this phenomenon, and loss aversion is modulated by thalamic norepinephrine
transmissions (Takahashi et al. 2013).
Because PG patients tend to have risk-taking personality and show reckless decision-
making (Slutske et al. 2005), the intuitive assumption is that PG patients would show
diminished loss aversion, as seen in amygdala lesion patients (De Martino et al. 2010). On
the other hand, a recent field study reported that internet problem gamblers tended to show
loss aversive or risk aversive decision-making during chasing, pointing to a relationship
between loss aversion and chasing (Xuan and Shaffer 2009). After losing money to
gambling, PG patients appear to be chasing their losses (continue gambling) to get even.
The value function, which is concave in a gain area and convex in a loss area, explains the
typically observed pattern of risk-seeking for losses and risk aversion for gains. Further-
more, loss aversion as expressed by a steeper slope in a loss area exaggerates risk-seeking
for losses and risk aversion for gains. A related cognitive bias concerned with loss aversion
in money investment is the disposition effect, which refers to a bias of investors who tend
to sell assets (risk aversion) when their price is rising, and keep them (risk-seeking) when
their price is falling. Although this could be mainly explained by the fact that the value
function is concave in a gain area and convex in a loss area, the loss aversion (a steeper
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slope of the value function in a loss area) could exaggerate this bias (Kahneman and
Tversky 1979; Shefrin and Statman 1985). It is thought that the difficulty of selling assets
when their price is falling (loss cut) is similar to the difficulty of deciding when to stop in
losing gambles (chasing). Another study reported that PG patients in a late treatment stage
showed greater loss aversion than healthy control (HC) subjects, whereas PG patients in an
early treatment stage showed similar loss aversion to HC subjects (Giorgetta et al. 2014).
Indeed, these previous studies suggested that the role of loss aversion in decision-making
of PG is not so straightforward.
Previous studies indicated the existence of subtypes in PG on the basis of personality
traits (Graham and Lowenfeld 1986; McCormick 1988; Moran 1970; Steel and
Blaszczynski 1996; Zimmerman et al. 1985). The pathways model was advocated based on
those previous studies (Blaszczynski and Nower 2002) and indicated two subtypes deeply
related with personality traits. One group is called ‘emotionally vulnerable problem
gamblers’. They are characterized by premorbid anxiety and/or depression, and have poor
skills of coping and solving problems. The other group is called ‘antisocial impulsivist
problem gamblers’. Their characteristic personality traits are high impulsivity and/or high
excitement-seeking.
The effectiveness of drugs directed at these personality traits was examined for PG. The
effects of antidepressant drugs, which are effective against anxiety and depression, have so
far provided mixed results (Black et al. 2007; Blanco et al. 2002; Grant et al. 2003;
Hollander et al. 2000; Kim et al. 2002; Saiz-Ruiz et al. 2005), and the effect of drugs
utilized for attention deficit hyperactivity disorder (ADHD), a disorder related to impul-
sivity and excitement-seeking, for example, amphetamine (Zack and Poulos 2004) and
modafinil (Smart et al. 2013), was also examined for PG, but a pharmacological treatment
for PG remains to be established. This also suggests that PG is a heterogeneous disorder
with personality traits.
Here, we aimed to examine loss aversion of PG using behavioral economics tools that
can directly approach gambling behaviors and personality traits. We hypothesized that PG
was heterogeneous in terms of loss aversion and that loss aversion would be associated




The PG group consisted of 31 male patients who were referred to a treatment facility. The
age-matched HC group consisted of 26 healthy male controls. All HC subjects were
recruited from a local community. All PG subjects met the criteria for PG according to
DSM-IV-TR, and PG symptoms were investigated using the Structured Clinical Interview
for Pathological Gambling (SCI-PG) (Grant et al. 2004). Comorbid disorders were
screened with the Structure Clinical Interview for DSM-IV-TR. The treatment facility is a
residential facility where PG patients receive 12-step-based psychological therapy. All PG
subjects were medication-free and participated after they had completed at least one cycle
of 12-step-based intervention (about 1 month). HC subjects were also evaluated with the
Structured Clinical Interview for DSM-IV-TR, and were found to have no history of any
psychiatric disorders. All PG subjects were physically healthy at the time of the
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assessment. None of the subjects had a history of neurological injury or disease, severe
medical disease, or illegal substance abuse that might affect brain function. Demographic
data of all subjects were collected with respects to age, education level, and smoking
status. Smoking status was evaluated with the Fagerstro¨m Test for Nicotine Dependence
(FTND) (Heatherton et al. 1991). We assert that all procedures contributing to this work
complied with the ethical standards of the relevant national and institutional committees on
human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and
ensure that subjects’ confidentiality was in no way breached. This study was approved by
the Committee on Medical Ethics of University and was carried out in accordance with the
Code of Ethics of the World Medical Association. After offering a complete description of
the study, written informed consent was obtained from all subjects.
Experimental Procedures
Clinical Assessment
We assessed gambling severity using the South Oaks Gambling Screen (SOGS) (Lesieur and
Blume 1987). SOGS is a 16-item self-administered questionnaire, ranging from 0 to 20. A
score of 5 or higher indicates a risk of pathological gambling. We assessed symptoms of
craving, which is common to addictive disorders, using the Gambling Craving Scale (GACS)
(Young and Wohl 2009). GACS is a 9-item self-administered questionnaire assessed with a
7-point scale. A higher score indicates more intense craving. Duration of illness and absti-
nence were determined by questioning the PG subjects. We assessed IQ using predicted IQ
based on the Japanese Adult Reading Test (JART) short form (Matsuoka and Kim 2007).
Personality Assessment
We assessed personality traits using Revised NEO Personality Inventory (NEO-PI-R)
(Costa and McCrae 1992). NEO-PI-R is based on the five-factor model of personality using
240 items. The five factors consist of neuroticism, extraversion, openness, agreeableness,
and conscientiousness. Then, we used the score of the five factors and four subscales:
anxiety, depression, impulsiveness, and excitement-seeking based on the pathways model
(Blaszczynski and Nower 2002).
Risky Choice Task
The behavioral loss aversion parameter for each subject was determined based on a
staircase procedure suggested by Tversky and Kahneman (Tversky and Kahneman 1992).
We used a gambling task to measure the behavioral loss aversion parameter. This task was
the same as that used in a previous study (Takahashi et al. 2013). The subjects were
presented with options between a mixed gamble (gain-loss) and a ‘‘stay’’ option on a
computer monitor. Each mixed gamble had a 50 % chance of losing a fixed amount of X
and a 50 % chance of gaining Y. A ‘‘stay’’ option was described as a mixed gamble that
had a 50 % chance of losing 0 yen and a 50 % chance of gaining 0 yen (i.e., getting 0 yen
for sure). We used 4 different possible losses (-X): -2500 yen, -5000 yen, -10,000 yen,
and -15,000 yen. In each trial, the subjects chose between the mixed gamble and the
‘‘stay’’ option. The relative position (left or right) of the two options was randomized to
counterbalance for order effects. The subjects were instructed as follows: ‘‘Two options of
1146 J Gambl Stud (2016) 32:1143–1154
123
a mixed gamble will be presented to you. Make a choice between the two options
according to your preference by pressing the right or left button. There is no correct answer
and no time limit. Once you make a choice, the next pair of options will be presented.
Actual remuneration does not reflect the result of the task.’’
Each time a choice was made between a mixed gamble and a ‘‘stay’’ option in a trial, the
amount of possible gain Y in the next trial was adjusted and ten trials of mixed gambles
with possible loss (-X) were iterated to successively narrow the range including the
amount of possible gain to make up for a 50 % chance of losing X. That is, we used a
titration method to ensure consistent choices of the subjects. The adjustments in the
amount of Y were made in the following manner. The initial range of Y was set between
0.5 9 X and 10 9 X. The range was divided into thirds. The one-third and two-thirds
intersecting points of the initial range were used as possible gain Y in trials 1 and 2. If the
subjects accepted the mixed gamble of the two-thirds and rejected the one-third in trials 1
and 2, the middle third portion of the initial range was used as a range for trials 3 and 4. If
the subjects accepted both mixed gambles of the thirds, the lower third part was then used
as range. If the subjects rejected both mixed gambles of the thirds, the upper third part was
then used. The new range was again divided into thirds and the same procedure was
iterated until the subject completed trial 10. The mean of the final range was used for the
amount of gain Yfinal to make up for a 50 % chance of losing X. Once Yfinal was estimated
for a given loss (-X), the gambles with the next loss (-X) were chosen for the estimation,
and so on. The order of X was randomized across the subjects.
The subjects performed the task in a silent room in the presence of an experimenter. The
experimenter checked the attitude of the subjects toward the task in order to exclude those
who did not engage in the task seriously, and confirmed that all the subjects completed the
task in a desirable manner.
Parameter Estimation and Statistical Analysis
The amount of gain Yfinal to make up for the 50 % chance of losing X is expressed as
Yfinal = k 9 X, where k is a loss aversion parameter. This k parameter is similar to the
parameter in prospect theory but makes the common simplifying assumptions of a linear
rather than a curvilinear value function, and identical decision weights for a 0.5 probability
of a gain or loss. (Note that the decision weight need not be equal to 0.5, as long as it is
assumed to be the same for the gain probability and the loss probability.) Based on
previous literature, we confined the range of k from 0.5 to 10 during the estimation
procedure. A smaller value of k (closer to 0.5) means less loss aversion (actually, loss-
seeking) and a higher value (closer to 10) means more loss aversion. The loss aversion
parameter k was estimated by least-squares method. Statistical analyses of demographic
data, clinical data, and the loss aversion parameter k was performed using SPSS (SPSS 22
for Windows, SPSS Inc., Chicago, IL, USA).
Results
Clinical and Personality Traits Assessment Between PG and HC
Clinical and personality traits assessment are summarized in Table 1 and tested by t tests.
PG subjects showed significantly lower educational level and predicted IQ based on JART,
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and higher scores of FTND and SOGS than HC subjects. As for the five factors of NEO-PI-
R, PG subjects showed significantly higher scores of neuroticism and lower scores of
conscientiousness (agreeableness was marginally significant) than HC subjects. The two
groups did not differ in terms of extraversion and openness. As predicted, PG subjects
showed significantly higher subscales of anxiety, depression, impulsiveness, and excite-
ment-seeking than HC subjects.
Loss Aversion Parameter Assessment Between PG and HC
Loss aversion parameter k in PG and HC subjects showed no significant correlation with
age, education level, smoking status, and predicted IQ based on JART. The range of loss
aversion parameter k was 0.52–9.98 (median = 2.13) in PG subjects and 0.98–9.98
(median = 3.74) in HC subjects. Mann–Whitney’s U tests showed that PG and HC
subjects did not differ in terms of loss aversion parameter k (PG: mean = 4.40,
SD = 3.95; HC: mean = 4.73, SD = 3.35; p = 0.37). Distributions of loss aversion
parameter k in PG and HC subjects are shown in Fig. 1. HC subjects showed a relatively
uniform distribution, whereas PG subjects visually showed a biased distribution toward
the two extremes, low and high. In order to investigate the distribution difference in
greater detail, we divided the PG and HC subjects into three groups in terms of
numerical value of loss aversion parameter k, 0–3.33 (subjects with low loss aversion),
3.34–6.66 (subjects with middle loss aversion), and 6.67–10.00 (subjects with high loss
Table 1 Clinical and psychometric characteristics of PG and HC subjects
Variable PG subjects (n = 31)
Mean ± SD
HC subjects (n = 26)
Mean ± SD
p value
Age (years) 33.4 ± 7.5 34.8 ± 6.3 0.45
Education level (years) 13.2 ± 1.9 16.6 ± 1.4 \0.001
FTND 3.5 ± 2.1 0.6 ± 1.4 \0.001
Predicted IQ based on JART 99.1 ± 9.5 111.3 ± 6.1 \0.001
SOGS 13.5 ± 2.4 0.3 ± 1.0 \0.001
GACS 21.0 ± 7.2
Duration of illness (years) 12.0 ± 7.2
Abstinence (months) 6.7 ± 6.7
NEO-PI-R
Neuroticism 117.6 ± 23.7 90.9 ± 17.8 \0.001
Extraversion 102.8 ± 18.0 100.0 ± 20.1 0.56
Openness 107.2 ± 15.2 110.2 ± 11.4 0.42
Agreeableness 103.9 ± 17.5 111.2 ± 10.6 0.06
Conscientiousness 87.3 ± 24.8 109.3 ± 18.8 \0.001
Anxiety 21.2 ± 5.8 17.4 ± 4.2 \0.01
Depression 20.8 ± 5.6 14.3 ± 3.7 \0.001
Impulsiveness 19.7 ± 5.0 15.2 ± 3.4 \0.001
Excitement-seeking 18.0 ± 4.2 15.5 ± 4.1 \0.05
FTND Fagerstro¨m Test for Nicotine Dependence, JART Japanese Adult Reading Test, SOGS South Oaks
Gambling Screen, GACS Gambling Craving Scale, NEO-PI-R Revised NEO Personality Inventory
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aversion). Based on this, the HC group consisted of 12 subjects with low loss aversion, 7
subjects with middle loss aversion, and 7 subjects with high loss aversion. On the other
hand, the PG group consisted of 19 subjects with low loss aversion, 1 subject with
middle loss aversion, and 11 subjects with high loss aversion. There was a significant
difference of distribution of loss aversion parameter k between PG and HC subjects
(Fisher’s exact test, p = 0.04).
Characteristics of a Lower Loss Aversion Group and a Higher Loss Aversion
Group in PG
According to the distribution of loss aversion in PG subjects, we compared the clinical
scales and personality traits mentioned above (the five factors, and anxiety, depression,
impulsiveness, excitement-seeking) between PG subjects with low loss aversion and PG
subjects with high loss aversion. Clinical scales and NEO-PI-R scales of the two groups
Fig. 1 a Distribution of loss aversion parameter k in PG subjects. b Distribution of loss aversion parameter
k in HC subjects
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were tested by t tests and summarized in Table 2. They did not show any significant
differences in terms of age, education level, FTND, predicted IQ based on JART, duration
of illness, abstinence, and the five factors of NEO-PI-R. There were significant differences
in terms of scores of GACS, anxiety and excitement-seeking between PG subjects with low
loss aversion and PG subjects with high loss aversion. PG subjects with low loss aversion
showed higher scores of GACS and excitement-seeking, and PG subjects with high loss
aversion showed higher score of anxiety. Anxiety of PG subjects with low loss aversion
was comparable to that of HC subjects (p = 0.22) and excitement-seeking of PG subjects
with high loss aversion was similar to that of HC subjects (p = 0.45) as tested by t tests.
We did not find any difference between HC subjects with low loss aversion and HC
subjects with high loss aversion.
Discussion
PG subjects showed higher neuroticism, lower conscientiousness, higher anxiety, higher
depression, higher impulsivity, and higher excitement-seeking than HC subjects. Inter-
estingly, there was no significant difference in loss aversion parameters between PG and
HC subjects. However, the distribution pattern of loss aversion parameters of PG subjects
was differed significantly from that of HC subjects. Although HC subjects were uniformly
classified into three levels (low, middle, high) of loss aversion, the majority of PG subjects
were classified into either low or high level, and PG subjects virtually lacked the middle
level. Therefore, we divided PG subjects into those with low loss aversion and those with
high loss aversion. PG subjects with low loss aversion showed higher craving intensity and
excitement-seeking than those with high loss aversion. PG subjects with high loss aversion
showed higher anxiety than those with low loss aversion. Without efforts to clarify the
difference in distributions between PG and HC subjects, it would seem at first glance that
Table 2 Clinical and psychometric characteristics of PG subjects with low and high loss aversion
Variable PG subjects with low loss aversion
(n = 19)
Mean ± SD




SOGS 13.0 ± 2.6 14.5 ± 1.7 0.09
GACS 24.4 ± 7.3 16.1 ± 3.7 \0.01
NEO-PI-R
Neuroticism 113.6 ± 26.4 122.0 ± 17.1 0.35
Extraversion 106.1 ± 18.1 97.5 ± 18.2 0.22
Openness 106.3 ± 14.7 107.8 ± 16.9 0.79
Agreeableness 104.8 ± 17.5 104.1 ± 18.2 0.91
Conscientiousness 89.3 ± 24.1 88.2 ± 23.4 0.91
Anxiety 19.3 ± 5.8 24.1 ± 4.5 \0.05
Depression 20.3 ± 5.8 20.6 ± 4.6 0.88
Impulsiveness 19.3 ± 5.6 19.9 ± 4.2 0.76
Excitement-
seeking
20.0 ± 3.7 14.5 ± 2.7 \0.001
SOGS South Oaks Gambling Screen, GACS Gambling Craving Scale, NEO-PI-R Revised NEO Personality
Inventory
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PG subjects uniformly have the same loss aversion and deviated personality traits based on
simple patient-control comparison. Although excitement-seeking, anxiety, depression and
impulsivity are generally higher in PG, PG subjects with low loss aversion showed high
excitement-seeking and normal level anxiety, and those with high loss aversion showed
high anxiety and normal level excitement-seeking.
We estimated loss aversion empirically using behavioral economics tools, which can
assess risk attitude in real-life decision-making (Camerer 2004; Kahneman and Tversky
1984). This is the first study to demonstrate the heterogeneity of risk attitude in PG subjects
and their relationships with personality traits. Since the pathways model was first proposed,
knowledge of personality traits in relation to PG has been growing rapidly (Bonnaire et al.
2009; Ledgerwood and Petry 2006; Ledgerwood and Petry 2010; Stewart et al. 2008;
Turner et al. 2008; Vachon and Bagby 2009). The current study could partly link the
knowledge of loss aversion with personality traits in PG. PG with low loss aversion, high
excitement-seeking and high craving intensity might partly coincide with ‘impulsivist
gamblers’ as proposed by the pathways model, and those with high loss aversion and high
anxiety might partly coincide with ‘emotionally vulnerable gamblers’. Previous studies
have examined chasing from the view of risk attitude, with mixed results. One study
reported that chasing reflected risk-taking attitude (Dickerson 1984), whereas a more
recent study demonstrated that chasing reflected risk-aversive attitude (Xuan and Shaffer
2009). Identifying the heterogeneity in loss aversion from the perspective of risk attitude is
very important in terms of understanding the cognitive and biological mechanisms of risk-
taking behaviors.
The beneficial outcome of efforts to identify the heterogeneity in terms of loss aversion
might also be useful for the development of treatment strategies for PG. PG subjects with
low loss aversion demonstrate high excitement-seeking, and they may have features similar
to the behavior of attention deficit hyperactivity disorder (ADHD) as proposed by the
pathways model, and may possess the characteristic neural substrate. A previous study
clarified that loss aversion has negative correlation with norepinephrine transporter (NET)
density in the thalamus (Takahashi et al. 2013). Because the NET blocker atomoxetine is
used in the treatment of ADHD, it might be worth considering the possible beneficial effect
of NET blocker for reckless decision-making in PG with low loss aversion. On the other
hand, pharmacological therapy that relieves anxiety, for example, anxiolytics and/or
antidepressants, might be useful for PG with high loss aversion.
There are several limitations to our study. For ethical reasons, we decided not to use real
money and gamble-related stimuli in abstinent and treatment-seeking PG patients. Con-
cerns that such provocative stimuli might trigger craving or relapse were expressed by the
treatment facility as well as the ethics committee. Although decision-making on hypo-
thetical rewards does not necessarily reflect real life decision-making, validity of the
results of experiments with hypothetical rewards has been reported (Locey et al. 2011).
Because the current study was a cross-sectional study, it remains unclear whether the loss
aversion parameter was modulated by treatment. A recent study showed that PG patients
with a longer treatment history were more loss aversive than those with a shorter treatment
history, implying that loss aversion could be modulated by treatment (Giorgetta et al.
2014). However, as that was also a cross-sectional study, it was difficult to actually
determine the causal effect of treatment on loss aversion. In the future, in addition to cross-
sectional research, longitudinal research to examine the treatment effect on loss aversion
while paying attention to excitement-seeking, anxiety, and craving intensity at the indi-
vidual level should be performed. We used only one behavioral task (loss aversion).
Comprehensive measurements with various behavioral economics tools are recommended
J Gambl Stud (2016) 32:1143–1154 1151
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to enable us to fully understand the heterogeneity of altered decision-making in PG.
Finally, all of the PG subjects in our study were undergoing treatment. It is estimated that
just a small portion of PG patients is actually undergoing active treatment at any one time.
Thus, any generalization of our findings needs to be approached with caution.
Conclusion
We could examine the heterogeneity of PG in terms of loss aversion using behavioral
economics tools. Although loss aversion in PG was not significantly different from that in
HC, our findings suggest that PG is not a uniform disorder but rather a heterogeneous
disorder with different risk attitudes. Future studies, especially neurobiological research,
are needed to better understand the pathophysiology and to develop novel treatments for
PG.
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